Document:

CONVERTIBLE PROMISSORY NOTE

 

THIS NOTE AND ANY SHARES OF STOCK ISSUABLE
UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS. THIS NOTE AND ANY SHARES OF STOCK ISSUABLE UPON THE CONVERSION HEREOF MAY NOT BE SOLD, OFFERED FOR SALE, MORTGAGED, PLEDGED,
HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT COVERING THIS NOTE OR SUCH SHARES UNDER
SAID ACT AND APPLICABLE STATE SECURITIES LAWS OR THE DELIVERY OF AN OPINION OF COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.
THIS NOTE IS ALSO SUBJECT TO RESTRICTIONS ON TRANSFER. 

 

Regen
BioPharma, Inc.

 

Issue Date: March 31, 2017Principal Amount:$50,000

 

1. Terms. For value
received, the Regen BioPharma, Inc., a Nevada corporation (the “Company”) hereby absolutely and unconditionally promises
to pay to the order of ____________ (the "Lender") ON DEMAND AT ANY TIME AFTER March 31, 2020 (the “Maturity Date”),
the principal amount of Fifty Thousand Dollars ($50,000) and interest on the whole amount of said principal sum outstanding and
remaining from time to time unpaid (the “Note”), commencing from the date hereof and continuing until payment in full
of this Note or conversion as hereinafter provided, at an annual rate equal to ten percent (10%) simple interest. Interest shall
be payable quarterly upon demand or upon conversion pursuant to Section 2 hereunder. Interest shall be computed on the basis of
the actual number of days elapsed divided by 365. Principal and interest shall be payable in lawful money of the United States
of America, at the principal place of business of the Lender or at such other place as the Lender may have designated from time
to time in writing to the Company.

 

2. Conversion.

 

2.1 Conversion Right.
The Lender shall have the right from time to time to convert all or a part of the outstanding and unpaid principal amount of this
Note into fully paid and non- assessable shares of Common Stock, as such Common Stock exists on the Issue Date, or any shares of
capital stock or other securities of the Company into which such Common Stock shall hereafter be changed or reclassified at the
conversion price (the “Conversion Price”) determined as provided herein (a “Conversion”). The Lender shall
have the right to convert one hundred percent (100%) of the Principal Amount immediately upon execution of this agreement and any
accrued interest may be converted as well.

 

The number of shares of
Common Stock to be issued upon each conversion of this Note shall be determined by dividing the principal amount of this Note to
be converted (the “Conversion Amount”) by the applicable Conversion Price as defined in this Section 2 then in effect
on the date specified in the notice of conversion, in the form attached hereto as Exhibit A (the “Notice of Conversion”),
delivered to the Company by the Lender on such conversion date (the “Conversion Date”).

 

2.2 Conversion Price.

The “Conversion Price” shall be defined as the lower
of $0.0125 per share or a 75% discount to the closing price of the Common Stock on the Over-the-Counter Bulletin Board on the trading
day immediately prior to the date that a Notice of Conversion is submitted pursuant to Section 2.3. or, if the Over-the-Counter
Bulletin Board is not the principal trading market for such security, the closing price of such security on the principal securities
exchange or trading market where such security is listed or traded on the trading day immediately prior to the date that a Notice
of Conversion is submitted pursuant to Section 2.3. or, if no closing bid price of such security is available in any of the foregoing
manners, the average of the closing bid prices of any market makers for such security that are listed in the “pink sheets”
by the National Quotation Bureau, Inc. on the trading day immediately prior to the date that a Notice of Conversion is submitted
pursuant to Section 2.3.

 

The Conversion Price shall be equitably adjusted for reverse
stock splits, forward stock splits, recapitalization, reclassifications, extraordinary distributions and similar events by the
Company relating to the Company’s Common Stock. Any adjustment made pursuant to this Section 2.2 shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and
shall become effective immediately after the effective date in the case of a reverse stock split, forward stock split, or reclassification

 

2.3 Method of Conversion.
Subject to Section 2.1, this Note may be converted by the Lender by submitting to the Company a Notice of Conversion by facsimile,
e-mail or other reasonable means of communication dispatched on the Conversion Date prior to 5:00 p.m., New York, New York time.
The Lender shall not be required to physically surrender this Note to the Company unless the entire unpaid principal amount of
this Note is so converted. The Lender and the Company shall maintain records showing the principal amount so converted and the
dates of such conversions so as not to require physical surrender of this Note upon each such conversion. In the event of any dispute
or discrepancy, such records of the Company shall, prima facie, be controlling and determinative in the absence of manifest error.
Notwithstanding the foregoing, if any portion of this Note is converted as aforesaid, the Lender may not transfer this Note unless
the Lender first physically surrenders this Note to the Company, whereupon the Company will forthwith issue and deliver upon the
order of the Lender a new Note of like tenor, registered as the Lender (upon payment by the Lender of any applicable transfer taxes)
may request, representing in the aggregate the remaining unpaid principal amount of this Note.

 

Upon receipt by the Company
from the Lender of a facsimile transmission, e-mail, or other reasonable means of communication of a Notice of Conversion meeting
the requirements for conversion, the Company shall issue and deliver or cause to be issued and delivered to or upon the order of
the Lender certificates for the Common Stock issuable upon such conversion within ten (10) business days after such receipt. Upon
receipt by the Company of a Notice of Conversion, the Lender shall be deemed to be the Lender of record of the Common Stock issuable
upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on this Note shall be reduced
to reflect such conversion. All rights with respect to the portion of this Note being so converted shall forthwith terminate except
the right to receive the Common Stock or other securities as herein provided on such conversion. In lieu of delivering physical
certificates representing the Common Stock issuable upon conversion, provided the Company is participating in the Depository Trust
Company (“DTC”) Fast Automated Securities Transfer (“FAST”) program, upon request of the Lender, the Company
shall use its best efforts to cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to
the Lender by crediting the account of Lender’s Prime Broker with DTC through its Deposit Withdrawal Agent Commission (“DWAC”)
system.

 

2.4 Concerning the
Shares. The shares of Common Stock issuable upon conversion of this Note may not be sold or transferred
unless (i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the Company or its transfer
agent shall have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions
of counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant
to an exemption from such registration or (iii) such shares are sold or transferred pursuant to Rule 144 under the Act (or a successor
rule) ("Rule 144") or (iv) such shares are transferred to an "affiliate" (as defined in Rule 144) of the Company
who agrees to sell or otherwise transfer the shares only in accordance with this Section 2.5 and who is an Accredited Investor
as the term Accredited Investor is defined in Rule 501 of Regulation D, promulgated under the Act.

 

Subject to the removal
provisions set forth below, until such time as the shares of Common Stock issuable upon conversion of this Note have been registered
under the Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular
date that can then be immediately sold, each certificate for shares of issuable upon conversion of this Note that has not been
so included in an effective registration statement or that has not been sold pursuant to an effective registration statement or
an exemption that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate:

 

"NEITHER THE ISSUANCE
OR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE
OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF
COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE LENDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER
SAID ACT."

 

The legend set forth above
shall be removed and the Company shall issue to the Lender a new certificate therefore free of any transfer legend if (i) the Company
or its transfer agent shall have received an opinion of counsel, in form, substance and scope customary for opinions of counsel
in comparable transactions, to the effect that a public sale or transfer of such Common Stock may be made without registration
under the Act and the shares are so sold or transferred, (ii) such Lender provides the Company or its transfer agent with reasonable
assurances that the Common Stock issuable upon conversion of this Note (to the extent such securities are deemed to have been acquired
on the same date) can be sold pursuant to Rule 144 or (iii) in the case of the Common Stock issuable upon conversion of this Note,
such security is registered for sale by under an effective registration statement filed under the Act or (iv) otherwise may be
sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately
sold.

 

3. Payment.

 

 

WIRE INSTRUCTIONS:

______

 

 

4. Prepayment. Notwithstanding
anything to the contrary contained herein, the Company shall have the right, exercisable on not less than ten (10) Trading Days
prior written notice to the Lender, to prepay the outstanding Note in part or in full, including outstanding principal and accrued
interest. Any notice of prepayment hereunder shall be delivered to the Lender at its registered addresses and shall state that
the Company is exercising its right to prepay the Note and the date of prepayment, which shall be not more than ten (10) Trading
Days from the date of the prepayment notice. Upon receipt of a prepayment notice, Lender shall have the right, but not the obligation,
to accelerate the conversion period specified in Section 2.1 and convert that portion of the outstanding principal balance which
is subject to prepayment to Common Shares as provided for in Section 2.

 

5. Warrant Coverage.
In the event that that the Company exercises its right to prepay the note, or if the Lender chooses not to convert the remaining
amount of the note into Common Shares of the company, the Lender shall receive warrants equal to 10% of the Common shares it would
have received had the Lender converted the remaining amount of the Note into Common shares of the Company. The warrants shall have
a strike price of $0.05 per share. See Exhibit B (incorporated into this Note) for instructions on completing the Exercise of Warrants
document.

 

6. Events of Default.

 

6.1 The following shall
constitute events of default (individually an "Event of Default"):

 

(a) default in the payment,
when due or payable, of an obligation to pay interest or principal under this Note, which default is not cured by payment in full
of the amount due within thirty (30) days from the date that the Lender receives notice of the occurrence of such default;

 

(b) filing of a petition
in bankruptcy or the commencement of any proceedings under any bankruptcy laws by or against the Company, which filing or proceeding,
is not dismissed within ninety (90) days after the filing or commencement thereof; or

 

(c) failure of the Company
to comply in any way with the terms, covenants or conditions contained in this Note.

 

6.2 If an Event of Default
shall occur and be continuing, the Lender may, at its option, declare this Note to be immediately due and payable without further
notice or demand, whereupon this Note shall become immediately due and payable without presentment, demand or protest, all of which
are hereby waived by the Company.

 

7. Transfer of Note. This Note may not
be transferred or assigned other than a transfer or assignment to an Affiliate of the Lender. As used herein, the term “Affiliate”
means an entity that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common
control with, the Lender.

 

8. Certain Waivers.
The Company hereby expressly and irrevocably waives presentment, demand, protest, notice of protest and any other formalities of
any kind.

 

9. Amendment, Modification
or Termination. This Note may only be modified, amended, or terminated (other than by payment in full) by an agreement in writing
signed by the Company and the Lender. No waiver of any term, covenant or provision of this Note shall be effective unless given
in writing by the Lender.

 

10. Governing Law.
This Note and the obligations of the Company hereunder shall be governed by and interpreted and determined in accordance with the
laws of the State of California (excluding the laws and rules of law applicable to conflicts or choice of law).

 

IN
WITNESS WHEREOF, this Note has been duly executed on behalf of the undersigned on the day and in the year first above written.

 

	REGEN BIOPHARMA, INC.	 
	 	 
	/s/ David
    R. Koos	3/31/2017
	David R. Koos	Date
	Chairman and CEO	 

 

The
foregoing Convertible Promissory Note is hereby accepted and agreed to by the undersigned on and as of the date first above written.

 

	 	 
		
	Name	Date
	Title	 

 

 

    	1 

    	 

    

 

EXHIBIT A

NOTICE OF CONVERSION

 

The undersigned hereby elects to convert $
_______________ principal amount and $____________ accrued interest of the Note into that number of shares of Common Stock to be
issued pursuant to the conversion of the Note as set forth below of REGEN BIOPHARMA, INC. according to the conditions of the convertible
note of the Company dated as of Month 00, 2020 as of the date written below.

 

	Date of Conversion:	 	 
	Applicable Conversion Price:	 	 
	(Attach
    Bloomberg price documentation)	 
	Number of Shares
    of Common Stock to be Issued Pursuant to Conversion of the Note:	 	 
	 	 	 
	Amount of Principal
    Balance Due Remaining Under the Note After This Conversion:	 	 

 

Checked
box corresponds to applicable instructions:

 

☐The
Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
or its nominee with DTC through its Deposit Withdrawal Agent Commission system (“DWAC Transfer”).

 

	Name of DTC Prime Broker:	 	 
	Account Number:	 	 

 

☐
The undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock
set forth below in the name(s) specified immediately below or, if additional space is necessary, on an attachment hereto:

 

	Name:	 	 
	Address:	 	 
	 	 	 
	 	 	 
	Phone:	 	 

 

 

	 	 
		
	Name	Date
	Title	 

 

    	2 

    	 

    

 

 

EXHIBIT B

 

COMMON STOCK PURCHASE WARRANT

REGEN BIOPHARMA, INC.

 

THIS WARRANT AND THE SHARES
ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND
THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF
AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EXEMPTION OR SAFE HARBOR PROVISION.

 

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies
that, for value received, Lender is entitled, solely upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, to subscribe for and purchase from the Company, shares of common stock of the Company (the “Warrant
Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the $0.05 per Warrant Share (“Exercise
Price”).

 

		1.	In the event that Company shall exercise Company’s rights pursuant to Section 4 of the Note (“Prepayment Clause”)
, Lender shall be entitled , on or prior to the close of business on the three (3) month anniversary of the date that the Note
shall have been prepaid by the Company(“Prepayment Date”) , to subscribe for and purchase from the Company up to that
number of Warrant Shares at the Exercise Price per Share equivalent to that one tenth of that number of Common Shares that Lender
would have been entitled to be issued had Lender exercised Lender’s Conversion Right pursuant to Section 2.1 of the Note
as of the Prepayment Date.

 

		2.	In the event that, as of the Maturity Date, part of the outstanding and unpaid principal amount of this Note and any Accrued
Interest remains outstanding, Lender shall be entitled , on or prior to the close of business on the three (3) month anniversary
of the Maturity Date , to subscribe for and purchase from the Company up to that number of Warrant Shares at the Exercise Price
per Share equivalent to that one tenth of that number of Common Shares that Lender would have been entitled to be issued had Lender
exercised Lender’s Conversion Right pursuant to Section 2.1 of the Note as of the Maturity Date.

 

		3.	If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common
Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of
reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such
event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3 shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision, combination or reclassification

 

		4.	Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, from and after the initial exercise
date, and then at any time, by delivery to the Company (or such other office or agency of the Company as it may designate by notice
in writing to Lender at the address of the Lender appearing on the books of the Company) of a duly executed facsimile or emailed
copy of the Notice of Exercise form annexed hereto and delivery of the aggregate Exercise Price for the Warrant Shares specified
in the applicable Notice of Exercise by wire transfer.

 

		5.	Warrant Shares purchased hereunder will be delivered to Holder within ten (10 ) business days of Notice of Exercise.

 

	 	6.	The Warrant Shares may not be sold or transferred unless (i) such shares are sold pursuant to an effective registration statement
under the Act or (ii) the Company or its transfer agent shall have been furnished with an opinion of counsel (which opinion shall
be in form, substance and scope customary for opinions of counsel in comparable transactions) to the effect that the shares to
be sold or transferred may be sold or transferred pursuant to an exemption from such registration or (iii) such shares are sold
or transferred pursuant to Rule 144 under the Act (or a successor rule) ("Rule 144") or (iv) such shares are transferred
to an "affiliate" (as defined in Rule 144) of the Company who agrees to sell or otherwise transfer the shares only in
accordance with this Section 6 and who is an Accredited Investor as the term Accredited Investor is defined in Rule 501 of Regulation
D, promulgated under the Act.

 

Subject to the
removal provisions set forth below, until such time as the Warrant Shares have been registered under the Act or otherwise may be
sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately
sold, each certificate for Warrant Shares that have not been so included in an effective registration statement or that have not
been sold pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear a legend
substantially in the following form, as appropriate:

 

"NEITHER
THE ISSUANCE OR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN
THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B)
AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE LENDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT."

 

The legend set
forth above shall be removed and the Company shall issue to the Lender a new certificate therefore free of any transfer legend
if (i) the Company or its transfer agent shall have received an opinion of counsel, in form, substance and scope customary for
opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such securities may be made without
registration under the Act and the shares are so sold or transferred, (ii) such Lender provides the Company or its transfer agent
with reasonable assurances that the Warrant Shares can be sold pursuant to Rule 144 or (iii) such security is registered for sale
by under an effective registration statement filed under the Act or (iv) otherwise may be sold pursuant to Rule 144 without any
restriction as to the number of securities as of a particular date that can then be immediately sold.

 

		7.	The Lender shall not be required to physically surrender this Warrant to the Company. If the Lender has purchased all of the
Warrant Shares available hereunder and the Warrant has been exercised in full, this Warrant shall automatically be cancelled without
the need to surrender the Warrant to the Company for cancellation.

 

		8.	This Warrant may not be transferred or assigned other than a transfer or assignment to an Affiliate of the Lender. As used
herein, the term “Affiliate” means an entity that directly, or indirectly through one or more intermediaries, controls,
or is controlled by, or is under common control with, the Lender.

 

		9.	FORM OF WARRANT NOTICE

 

 

NOTICE OF EXERCISE

 

To:REGEN BIOPHARMA,
INC.

 

The undersigned hereby
elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the Warrant issued in connection with that Convertible
Note in the amount of _______ by and between ______ and the Company dated _____ and maturing _____, 2020 and tenders herewith payment
of the exercise price in full, together with all applicable transfer taxes, if any.

Please issue a certificate or certificates representing said Warrant
Shares in the name of the undersigned. The undersigned is an “accredited investor” as defined in Regulation D promulgated
under the Securities Act of 1933, as amended.

 

[SIGNATURE]

 

 

Name: _______________________________________

Date: ________________________________________

 

 

    	3Investor
Relations Consulting Agreement Between

Regen
Biopharma Inc. And Synergy Business Consultants LLC

 

This
document acts forth the agreement Regen Biopharma Inc. (“the Company”) and Synergy Business Consultants LLC concerning
Investor Relation and Financial Public Relation services rendered to the Company from February 24, 2017 and continuing through
March 24, 2017. (1 month).

 

When
countersigned in the spaces provided on the last page, this document shall serve as our agreement, as detailed below. Therefore,
the Agreement contains the full and complete understanding between the parties and supersedes all prior understandings. It is
further understood/agreed (when countersigned) that this Agreement may not be altered, modified or changed in any way without
the expressed written consent of both parties.

 

WITNESSETH

 

WHEREAS,
the Company requires Investor Relation services and Financial Public Relation services and desires to engage Synergy Business
Consultants LLC to provide such services; and

 

WHEREAS,
Synergy Business Consultants LLC is agreeable to such engagement on the terms set forth herein; and

 

WHEREAS,
the parties mutually desire to enter into this Consulting Agreement,

 

NOW,
THEREFORE, in consideration of the mutual promises and covenants contained herein, the parties have agreed as follows:

 

    	1 

    	 

    

1.
APPOINTMENT

The
Company hereby appoints Synergy Business Consultants LLC as its non-exclusive Investor Relations and Financial Public Relations
advisor and retains and engages Synergy Business Consultants LLC under the terms and conditions of this Agreement.

 

2.
TERM

The
term of this Agreement shall be for a period of 1 month (the "Initial Term") and upon written request by the Company
shall be renewed for an additional 1 month periods (the "Renewal Terms"). There are no auto renewal terms.

 

3.
OBLIGATIONS OF SYNERGY BUSINESS CONSULTANTS LLC

Synergy
Business Consultants LLC agrees to their best efforts to do or perform the following services:

a.
Coordinate investor relation and corporate financial public relation efforts.

b.
Seek to make the Company, its management, its products and prospects known to the financial press and publications, broker-dealers,
mutual funds, institutional investors, market makers, analysts, investment advisors, and other members of the financial community
as well as the financial media and the public generally.

c.
Arrange and manage company presentations through conference calls, personal interface and other means of direct presentations
to audiences, which may include stockbrokers, individual and institutional investors, money managers, analysts, etc.

d.
Provide introduction to its network of individuals, firms and brokers for the purpose of participating in scheduled meetings or
conference calls with the Company for the purpose of disseminating information and responding to questions from said parties.

e.
Be available to the Company to field any calls / emails from individuals, firms and brokers inquiring about the Company.

 

    	2 

    	 

    

f.
Obtain for the Company exposure in various financial media, independent financial newsletters and through online, fax and Internet/Email
broadcast services.

g.
The direct costs related to any of the services outlined above or in other parts of this Agreement will be either directly invoiced
to the Company or billed by Synergy Business Consultants LLC to the Company, upon prior written consent. The Company agrees to
promptly reimburse Synergy Business Consultants LLC for any such costs within fifteen (15) days of invoice.

 

4.
LIMITATIONS ON SERVICES

The
parties recognize that certain responsibilities and obligations are imposed by Federal and State securities laws and by the applicable
rules and regulations of stock exchanges, the National Association of Securities Dealers, Inc. and the compliance rules of brokerage
houses and other sources.

 

Accordingly,
Synergy Business Consultants LLC agrees:

a.
Synergy Business Consultants LLC shall not release any financial or other material information or data about the Company without
the consent and approval of the Company.

b.
Synergy Business Consultants LLC shall not conduct any meetings with financial analysts without informing the Company in advance
of the proposed meeting and the format or agenda of such meeting.

c.
Synergy Business Consultants LLC shall not release any information or data about the Company to any selected or limited person(s),
entity, or group if the Synergy Business Consultants LLC is aware that such information or data has not been generally released
or promulgated.

d.
After notice by the Company of filing for a proposed public offering of securities of the Company and during any period of restriction
on publicity, Synergy Business Consultants LLC shall not engage in any public relations efforts without approval of counsel of
the Company and of counsel of the underwriter(s), if any.

 

    	3 

    	 

    

5.
DUTIES OF COMPANY

In
recognition of the responsibilities set forth in the preceding paragraph 4, the Company agrees:

a.
Within seven days of the date of execution of this Agreement, to deliver to Synergy Business Consultants LLC a complete due diligence
package on the Company including all the Company's filings with the Securities and Exchange Commission, if any, all press releases
written about the Company and all other relevant materials with respect to such filings, including but not limited to corporate
reports, brochures, and the like, the Company’s business plan, all financial statements, audited and/or otherwise, and/or
a Proforma, a list of the names and addresses of all the Company's shareholders known to the Company and a list of the brokers
and market makers in the Company's securities and which have been following the Company.

b.
To supply Synergy Business Consultants LLC on a regular and timely basis with all approved data and information about the Company,
its management, its products and its operations. The Company shall be responsible for advising Synergy Business Consultants LLC
of any facts which would affect the accuracy of any prior data and information supplied to Synergy Business Consultants LLC. The
Company shall supply Synergy Business Consultants LLC with a list of new shareholders (including names and addresses) of the Company’s
stock within 10 business days from execution of this agreement.

c.
To promptly supply Synergy Business Consultants LLC with full and complete files of all shareholder reports and communications
(whether or not prepared with Synergy Business Consultants LLC’s assistance), with all data and information supplied to
any analyst, broker-dealer, market maker, or other member of the financial community and with all product/services brochures,
sales materials, etc.

 

    	4 

    	 

    

d.
To promptly notify Synergy Business Consultants LLC of the filing of any registration statement for the sale of securities and
of any other event which triggers any restrictions on publicity.

e.
To notify Synergy Business Consultants LLC if any information or data supplied to them that has not been generally released or
promulgated.

 

6.
REPRESENTATIONS 

Both
parties mutually agree to the following:

a.
The Company shall be deemed to make a continuing representation of the accuracy and currency of any and all material facts, material
information and data which it supplies to Synergy Business Consultants LLC, and the Company acknowledges its awareness that Synergy
Business Consultants LLC will rely on such continuing representation in disseminating such information and otherwise performing
its public relations functions.

b.
The Company shall immediately give written notice to Synergy Business Consultants LLC of any change in Company's financial condition
or in the nature of its business or operations which had or might have an adverse material effect on its operations, assets, properties
or prospects of its business. Synergy Business Consultants LLC in the absence of notice in writing from Company will rely on the
continuing accuracy of material, information and data supplied by the Company.

 

c.
SYNERGY BUSINESS CONSULTANTS LLC NOR ITS AFFILIATES MAKES NO REPRESENTATION OR GUARANTEES THAT (A) ITS SERVICE WILL RESULT
IN ANY ENHANCEMENT TO THE COMPANY (B) THE PRICE OF THE COMPANY'S PUBLICLY TRADED SECURITIES WILL INCREASE, (C) ANY PERSON WILL
PURCHASE SECURITIES IN THE COMPANY (D) ANY INVESTOR WILL LEND MONEY TO OR INVEST IN OR WITH THE COMPANY.

d.
The Company acknowledges and agrees that this is not a performance based Agreement. The Company also understands and agrees Synergy
Business Consultants LLC is not a broker dealer and does not recommend the purchase or sale of any securities, they do not have
the ability to and are not required to record, maintain or produce any shareholder records.

 

    	5 

    	 

    

7.
INDEMNIFICATION

 

Each
Party agrees to indemnify, defend and hold harmless the other Party and its directors, officers, employees, agents, successors
and assigns (collectively, the “Other Party Indemnitees”) from and against all liabilities, losses, damages and costs
(including reasonable attorneys’ fees) (collectively, “Losses”) they may suffer as the result of Third Party
claims, demands, actions, suits or judgments against them resulting from or arising out of: (a) the negligence, recklessness or
willful misconduct on the part of the indemnifying Party; (b) the failure by the indemnifying Party to comply with applicable
Laws in connection with the exercise of any of its rights or the performance of any of its obligations hereunder; and/or (c) any
breach of this Agreement by the indemnifying Party.

 

8.
COMPENSATION

Both
parties mutually agree to the following:

a.
The Company shall pay Synergy Business Consultants LLC a monthly cash fee of $5.000.00 (Five Thousand Dollars) on or before February
24, 2017.

b.
The Company agrees to issue Synergy Business Consultants 200,000 (Two Hundred Thousand.) shares of RGBP restricted common stock
and is due and fully payable on February 24, 2017. The Company agrees to sign and return any necessary paperwork from Synergy
Business Consultants LLC’s brokerage firm and/or transfer agent allowing the removal of the restrictive legend of all shares
issued through this contact within 5 business days of receiving them in accordance with SEC rules and regulations. The Company
also agrees to include the issuance of shares through this agreement in their next filed 10-Q or 10-K. The Company also agrees
to have The Company’s’ legal counsel issue a 144 opinion letter to Synergy Business Consultants on or before August
25, 2017 at the Company’s expense.

 

    	6 

    	 

    

c.
In the event that the Synergy Business Consultant introduces a third party to the Company and
the third party or the any of the third party’s affiliates provides the Company financing within one year of the introduction,
Business Consultants LLC will be paid an introduction fee in the amount of 5% upon closing of the financing. The Company
agrees not to circumvent Synergy Business Consultants LLC in any way after an introduction has been made. The
Company agrees to wire the funds via bank wire within 5 days of receiving the funds. In the event that the financing is in the
form of an equity line of credit, the 5% shall be paid within 5 business days of each upon each drawn down via bank wire. 

 

9.
BILLING AND PAYMENT

The
monthly basic fee provided in Paragraph 8(a) and 8(b) shall be due and payable without billing upon execution of this Agreement
and on each monthly anniversary date of this Agreement. Billings and payments for special services Paragraph 7(c) shall be as
agreed. Billings and payments for out-of-pocket expenses approved in advance in writing by the Company incurred by Synergy Business
Consultants LLC shall be reimbursed within five (5) business days by the Company as incurred and invoiced by Synergy Business
Consultants LLC to the Company. Company shall have no obligation to reimburse Synergy Business Consultants LLC any expenses which
have not previously been approved in writing by the Company.

 

The
Company may elect to pay up front or reimburse Synergy Business Consultants LLC for expenses incurred in the performance of the
obligations of Synergy Business Consultants LLC which expenses include but are not necessarily limited to the following costs
and expenses ( provided all expense items are approved by the Company in writing) prior to Synergy Business Consultants LLC’s
incurrence of the same: `

    	7 

    	 

    

 

a.
Travel expenses, including but not limited to transportation, lodging and food expenses, when such travel is conducted on behalf
of the Company.

b.
Seminars, expositions, money and investment shows.

c.
Radio and television time and print media or online advertising costs, when applicable.

d.
Subcontract fees and costs incurred in preparation of, including but limited to research reports, when applicable.

e.
Cost of on-site due diligence meetings, if any.

f.
Printing and publication costs of brochures and marketing materials which are not supplied by the Company.

g.
Printing and publication costs of the Company's annual reports, quarterly reports, and/or other shareholder communication collateral
material which are not supplied by the Company.

 

The
Company shall pay Synergy Business Consultants LLC’s costs and expenses incurred within five (5) days of receipt Synergy
Business Consultants LLC’s written invoice for the same provided the aforementioned costs and expenses have been previously
approved in writing by the Company.

 

Synergy
Business Consultants LLC agrees that no expense to the Company shall be incurred without prior written approval from the Company.

 

10.
RELATIONSHIP OF PARTIES

Synergy
Business Consultants LLC is an independent contractor, and is responsible for compensation of its own agents, employees and representatives,
as well as all applicable withholding taxes thereon (including unemployment compensation) and all workers’ compensation
insurance. This Agreement does not establish any partnership, joint venture, or other business entity or association between the
parties.

 

    	8 

    	 

    

11.
ATTORNEY'S FEES

Should
either party default in the terms or conditions of this Agreement and suit be filed as a result of such default, the prevailing
party shall be entitled to recover all costs incurred as a result of such default including all costs and reasonable attorney
fees through trial and appeal.

 

12.
WAIVER OF BREACH

The
waiver by either party of a breach of any provision of this Agreement by the other party shall not operate or be construed as
a waiver of any subsequent breach by the other party.

 

13.
ASSIGNMENT

The
rights and obligations of the parties under this Agreement shall inure to the benefit of and shall be binding upon the successors
and assigns of the parties.

 

14.
NOTICES

Any
notice required or permitted to be given under this Agreement shall be sufficient if in writing, and if sent by certified mail,
return receipt requested, or UPS, Federal Express or similar carrier to the principal officer of the party being notified.

 

15.
SEPARABILITY

If
one or more of the provisions of this Agreement shall be held invalid, illegal, or unenforceable in any respect, such provision,
to the extent invalid, illegal, or unenforceable, and provided that such provision is not essential to the transaction provided
for by this Agreement, shall not affect any other provision hereof, and the Agreement shall be construed as if such provision
had never been contained herein.

 

16.
GOVERNING LAW, VENUE

All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.

    	9 

    	 

    

 

17.
ENTIRE AGREEMENT

This
instrument contains the entire agreement between the parties and may be modified only by agreement in writing, signed by the party
against whom enforcement of any waiver, change, modification, extension or discharge is sought.

 

 

IN
WITNESS WHEREOF, the parties hereto, intending to be legally bound, have executed this Agreement on this 23th day
of February, 2017 to be effective on February 24, 2017.

 

	/s/
    David Koos	 	 
	By: David Koos, CEO	 	 
	REGEN BIOPHARMA, INC.	 	 
	 	 	 
	 	 	 
	 	 	 
	/s/ Richard
    Severson	 	 
	By: Richard Severson, President	 	 
	Synergy Business Consultants LLC	 	 

 

    	10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]